While the economic environment remains complex and unpredictable, we assume growth will continue, inflation will remain higher for longer and currency translation impacts become more challenging. With the global energy surcharge mechanism implemented, total pricing is expected to accelerate further to keep us ahead of inflation, resulting in easing year-over-year margin pressure going forward. As we also prepare for a potentially more challenging macroeconomic environment, our primary focus will now shift to new business development to support our strong topline momentum. While this shift will naturally take some time to fully develop, we expect our overall performance to improve sequentially in the second half, though full year earnings will be impacted by increasing currency translation headwinds, now estimated to be $0.30 per share unfavorable for the full year, and the timing lag of the second quarter energy surcharge. We look for the third quarter to show continued strong sales growth and a sequentially narrowing decline in year-over-year adjusted diluted earnings per share comparisons, reflecting an estimated $0.10 per share impact from unfavorable currency translation and potentially softer volume growth as our team shifts their focus to new business. With total pricing expected to accelerate even further, reaching the low double-digit level in the second half, further new business wins, breakthrough innovation and continued productivity benefits, we expect the fourth quarter to show accelerating earnings growth, resulting in modest gains in full year 2022 adjusted earnings per share. Importantly, we expect to exit the year in a very strong position to get back to more traditional Ecolab-like performance going forward.
Home Newsfeeds Ecolab Says ‘we expect our overall performance to improve sequentially in the second half, though full year earnings will be impacted by increasing currency translation headwinds’
Ecolab Says ‘we expect our overall performance to improve sequentially in the second half, though full year earnings will be impacted by increasing currency translation headwinds’
While the economic environment remains complex and unpredictable, we assume growth will continue, inflation will remain higher for longer and currency translation impacts become more challenging. With the global energy
Related Posts
Akoya Biosciences Marks Milestone Achievement With Shipment Of 1,000th Spatial Biology Instrument
April 27, 8:23 AM
Akoya Biosciences, Inc. (NASDAQ:AKYA) ("Akoya"), The Spatial Biology Company®, today announced it has shipped it's 1,000th instrument, a significant milestone for the company and the largest
Life Insurers Better Positioned Heading Into 2024: Goldman Sachs
January 8, 2:43 PM
Goldman Sachs analyst Alex Scott changed the rating on several insurance stocks, expecting a mixed insurance industry environment in 2024, with potentially improving book value compounding.
The analyst is more positive about life insurers as he sees improved capital positions, stronger cash flow, and the lagged benefits of higher long-term interest rates.
Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $43
November 21, 8:24 AM
Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and lowers the price target from $45 to $43.